Annual Net Margin
N/A
December 31, 2023
Summary
- RGLS annual net profit margin is not available.
Performance
RGLS Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Margin
N/A
September 30, 2024
Summary
- RGLS quarterly net profit margin is not available.
Performance
RGLS Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
RGLS Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
RGLS Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Regulus Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -157.21%(-42.2%) | -26.44%(-13.3%) |
| Sep 2020 | - | -30.48%(-100.0%) |
| Mar 2020 | - | -98.95 K%(+264.0%) |
| Dec 2019 | -272.13%(-99.6%) | -27.18 K%(-9.8%) |
| Sep 2019 | - | -30.13 K%(+8.1%) |
| Jun 2019 | - | -27.87 K%(>+9900.0%) |
| Mar 2019 | - | -48.10%(-99.9%) |
| Dec 2018 | -67.65 K%(-32.3%) | -47.57 K%(-16.6%) |
| Sep 2018 | - | -57.07 K%(-25.8%) |
| Jun 2018 | - | -76.93 K%(-13.6%) |
| Mar 2018 | - | -89.03 K%(+10.9%) |
| Dec 2017 | -99.87 K%(+1357.1%) | -80.27 K%(-8.7%) |
| Sep 2017 | - | -87.93 K%(-26.7%) |
| Jun 2017 | - | -120.04 K%(+7.9%) |
| Mar 2017 | - | -111.23 K%(+0.0%) |
| Dec 2016 | -6853.94%(+2452.2%) | -111.22 K%(+1062.4%) |
| Sep 2016 | - | -9568.14%(+119.1%) |
| Jun 2016 | - | -4366.46%(+0.7%) |
| Mar 2016 | - | -4336.81%(+6417.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -268.55%(-63.7%) | -66.54%(-90.5%) |
| Sep 2015 | - | -697.05%(+27.1%) |
| Jun 2015 | - | -548.64%(+59.1%) |
| Mar 2015 | - | -344.93%(-34.4%) |
| Dec 2014 | -739.08%(+674.7%) | -525.43%(-41.9%) |
| Sep 2014 | - | -904.71%(-44.4%) |
| Jun 2014 | - | -1626.77%(+108.2%) |
| Mar 2014 | - | -781.18%(+2111.1%) |
| Dec 2013 | -95.40%(-30.4%) | -35.33%(-0.1%) |
| Sep 2013 | - | -35.37%(-77.1%) |
| Jun 2013 | - | -154.40%(-30.8%) |
| Mar 2013 | - | -223.26%(+5.1%) |
| Dec 2012 | -137.07%(+148.6%) | -212.35%(+4.9%) |
| Sep 2012 | - | -202.39%(+157.7%) |
| Jun 2012 | - | -78.54%(+16.9%) |
| Mar 2012 | - | -67.20%(+12.1%) |
| Dec 2011 | -55.13%(-69.5%) | -59.92%(+118.4%) |
| Sep 2011 | - | -27.44% |
| Dec 2010 | -180.90% | - |
FAQ
- What is the all time high annual net margin for Regulus Therapeutics?
- What is the all time high quarterly net margin for Regulus Therapeutics?
What is the all time high annual net margin for Regulus Therapeutics?
Regulus Therapeutics all-time high annual net profit margin is -55.13%
What is the all time high quarterly net margin for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly net profit margin is -26.44%